{"id":637,"date":"2026-02-28T14:01:11","date_gmt":"2026-02-28T14:01:11","guid":{"rendered":"https:\/\/heartcareforyou.in\/blog\/cardiac-rehabilitation-phase-ii-definition-clinical-context-and-cardiology-overview\/"},"modified":"2026-02-28T14:01:11","modified_gmt":"2026-02-28T14:01:11","slug":"cardiac-rehabilitation-phase-ii-definition-clinical-context-and-cardiology-overview","status":"publish","type":"post","link":"https:\/\/heartcareforyou.in\/blog\/cardiac-rehabilitation-phase-ii-definition-clinical-context-and-cardiology-overview\/","title":{"rendered":"Cardiac Rehabilitation Phase II: Definition, Clinical Context, and Cardiology Overview"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Cardiac Rehabilitation Phase II Introduction (What it is)<\/h2>\n\n\n\n<p>Cardiac Rehabilitation Phase II is a structured, medically supervised outpatient rehabilitation program after a cardiac event or procedure.<br\/>\nIt is a therapeutic care pathway, not a diagnosis or a test.<br\/>\nIt is commonly encountered after myocardial infarction (MI), percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), valve procedures, or heart failure (HF) stabilization.<br\/>\nIt combines monitored exercise training with education and risk-factor management to support safer recovery and long-term cardiovascular health.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Why Cardiac Rehabilitation Phase II matters in cardiology (Clinical relevance)<\/h2>\n\n\n\n<p>Cardiac rehabilitation is a core component of contemporary secondary prevention\u2014care aimed at reducing future cardiovascular events in people with established cardiovascular disease. Cardiac Rehabilitation Phase II matters because it operationalizes multiple evidence-informed goals in a single program: progressive physical reconditioning, symptom monitoring, medication understanding, lifestyle counseling, and coordinated follow-up.<\/p>\n\n\n\n<p>From a clinical reasoning perspective, Phase II functions as a \u201cbridge\u201d between the acute phase of care (hospitalization and early recovery) and long-term self-management. Many patients leave the hospital after MI, PCI, CABG, or decompensated HF with improving symptoms but ongoing physiologic vulnerability. Early outpatient rehabilitation provides a structured environment where clinicians can observe responses to graded activity, identify concerning patterns (for example, exertional chest discomfort, undue dyspnea, or arrhythmia symptoms), and reinforce guideline-directed therapies in a practical way.<\/p>\n\n\n\n<p>Phase II also supports risk stratification and care planning in general terms. Functional capacity, hemodynamic responses to exercise, symptom patterns, and adherence barriers often become clearer when patients engage in repeated, progressive sessions. These observations can inform subsequent decisions about activity progression, work considerations, and coordination with cardiology, primary care, and other specialties. The impact of rehabilitation varies by protocol and patient factors, but the clinical intent is consistent: improve functional recovery while supporting safer long-term cardiovascular risk management.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Classification \/ types \/ variants<\/h2>\n\n\n\n<p>Cardiac rehabilitation is often described in phases rather than \u201ctypes,\u201d and Phase II is one stage in that continuum. Common categorization frameworks include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>By rehabilitation phase (care timeline)<\/strong><\/li>\n<li><strong>Phase I:<\/strong> Inpatient\/early mobilization during hospitalization after a cardiac event or procedure.<\/li>\n<li><strong>Cardiac Rehabilitation Phase II:<\/strong> Structured outpatient program with supervised exercise and education.<\/li>\n<li>\n<p><strong>Phase III\/IV (terms vary):<\/strong> Longer-term maintenance programs or community-based exercise with less direct medical supervision.<\/p>\n<\/li>\n<li>\n<p><strong>By delivery model (program format)<\/strong><\/p>\n<\/li>\n<li><strong>Center-based supervised programs:<\/strong> Exercise sessions occur in a facility with staff, equipment, and monitoring capabilities.<\/li>\n<li><strong>Home-based or hybrid programs:<\/strong> Exercise occurs at home with remote coaching, periodic in-person visits, and individualized tracking; monitoring intensity varies by protocol and patient factors.<\/li>\n<li>\n<p><strong>Telehealth-supported models:<\/strong> Education and coaching delivered remotely; physiologic monitoring may be limited or technology-dependent.<\/p>\n<\/li>\n<li>\n<p><strong>By clinical population (indication-focused tracks)<\/strong><\/p>\n<\/li>\n<li><strong>Post\u2013acute coronary syndrome (ACS):<\/strong> After MI or unstable angina treatment.<\/li>\n<li><strong>Post-revascularization:<\/strong> After PCI or CABG.<\/li>\n<li><strong>Heart failure rehabilitation:<\/strong> Often focused on stable, chronic HF with attention to volume status and exertional symptoms.<\/li>\n<li><strong>Post\u2013valve intervention:<\/strong> After surgical or transcatheter valve procedures.<\/li>\n<li>Program eligibility and structure can vary by clinician and case.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Relevant anatomy &amp; physiology<\/h2>\n\n\n\n<p>Understanding Phase II rehabilitation is easier when linked to cardiovascular physiology\u2014especially oxygen delivery, cardiac output, and autonomic regulation during exercise.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Heart chambers and cardiac output<\/strong><\/li>\n<li>The left ventricle (LV) is the primary pump for systemic perfusion. After MI or cardiomyopathy, LV systolic function may be reduced, limiting stroke volume reserve during exertion.<\/li>\n<li>\n<p>The right ventricle supports pulmonary circulation; right-sided dysfunction can contribute to exertional intolerance and fluid congestion.<\/p>\n<\/li>\n<li>\n<p><strong>Coronary circulation<\/strong><\/p>\n<\/li>\n<li>Coronary arteries supply oxygen to myocardium. After coronary plaque rupture (ACS) or flow-limiting stenosis, ischemia can recur with increased myocardial oxygen demand.<\/li>\n<li>\n<p>Revascularization (PCI\/CABG) may improve supply, but ischemia can still occur depending on residual disease, microvascular function, vasomotor tone, and demand.<\/p>\n<\/li>\n<li>\n<p><strong>Valves and hemodynamics<\/strong><\/p>\n<\/li>\n<li>\n<p>Valve lesions (aortic stenosis, mitral regurgitation, etc.) alter pressure and volume loading conditions. Post-intervention patients may have improving hemodynamics but remain sensitive to rapid changes in preload\/afterload during early recovery.<\/p>\n<\/li>\n<li>\n<p><strong>Conduction system and rhythm<\/strong><\/p>\n<\/li>\n<li>The sinoatrial (SA) node, atrioventricular (AV) node, and His\u2013Purkinje system coordinate electrical activation. Scar from MI, postoperative inflammation, electrolyte shifts, or underlying conduction disease can predispose to arrhythmias.<\/li>\n<li>\n<p>Exercise increases sympathetic tone and decreases parasympathetic tone, influencing heart rate, conduction, and arrhythmia propensity.<\/p>\n<\/li>\n<li>\n<p><strong>Vascular and skeletal muscle physiology<\/strong><\/p>\n<\/li>\n<li>Exercise training improves peripheral oxygen extraction, endothelial function, and skeletal muscle efficiency. These peripheral adaptations can reduce cardiac workload for a given activity level over time.<\/li>\n<li>Blood pressure responses during exercise reflect vascular tone, LV function, and autonomic balance\u2014key observations during supervised sessions.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Pathophysiology or mechanism<\/h2>\n\n\n\n<p>Cardiac Rehabilitation Phase II is not a single \u201cmechanism\u201d like a drug; it is a multi-component intervention designed to address common physiologic and behavioral consequences of cardiovascular disease.<\/p>\n\n\n\n<p>Core mechanisms (conceptual, patient-specific) include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Graded exercise conditioning<\/strong><\/li>\n<li>Progressive aerobic and resistance training aims to improve functional capacity through central and peripheral adaptations.<\/li>\n<li>\n<p>Central effects can include improved stroke volume efficiency and autonomic regulation; peripheral effects include improved skeletal muscle oxidative capacity and vascular function. The balance of these effects varies by protocol and patient factors.<\/p>\n<\/li>\n<li>\n<p><strong>Ischemia and symptom surveillance during recovery<\/strong><\/p>\n<\/li>\n<li>After ACS or revascularization, exertional symptoms may reflect residual ischemia, vasospasm, anemia, pulmonary disease, deconditioning, medication effects, or other etiologies.<\/li>\n<li>\n<p>Supervised sessions create a structured context to detect patterns and prompt appropriate clinical follow-up when needed.<\/p>\n<\/li>\n<li>\n<p><strong>Risk factor modification and secondary prevention<\/strong><\/p>\n<\/li>\n<li>Education targets modifiable risks (tobacco exposure, physical inactivity, diet quality, blood pressure control, lipid management, diabetes care, sleep, and psychosocial stressors).<\/li>\n<li>\n<p>Reinforcing medication purpose and adherence supports physiologic goals such as heart rate control, blood pressure management, anti-ischemic therapy, antithrombotic therapy when indicated, and lipid lowering.<\/p>\n<\/li>\n<li>\n<p><strong>Behavioral and psychosocial support<\/strong><\/p>\n<\/li>\n<li>Anxiety, depressive symptoms, and fear of exertion are common after cardiac events and can drive avoidance and deconditioning.<\/li>\n<li>Structured coaching and reassurance based on observed physiologic responses can reduce uncertainty and improve engagement.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Clinical presentation or indications<\/h2>\n\n\n\n<p>Cardiac Rehabilitation Phase II is typically initiated after stabilization from a cardiac diagnosis or procedure. Common clinical scenarios include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Recent <strong>myocardial infarction (MI)<\/strong> managed medically or with PCI.<\/li>\n<li>Recovery after <strong>coronary artery bypass grafting (CABG)<\/strong>.<\/li>\n<li>Post-<strong>PCI<\/strong> (stent placement) for stable ischemic heart disease or ACS.<\/li>\n<li>Stable <strong>heart failure (HF)<\/strong> after optimization of therapy and clinical stabilization.<\/li>\n<li>After <strong>valve surgery<\/strong> or <strong>transcatheter valve intervention<\/strong>, once clinically stable.<\/li>\n<li>Selected patients after <strong>cardiac transplantation<\/strong> or with <strong>implantable devices<\/strong> (for example, pacemaker or implantable cardioverter-defibrillator), depending on program protocols and care team goals.<\/li>\n<li>Patients with persistent <strong>deconditioning<\/strong>, reduced exercise tolerance, or uncertainty about safe activity progression after hospitalization for a cardiac condition.<\/li>\n<\/ul>\n\n\n\n<p>Eligibility timing and specifics vary by clinician and case, and programs typically coordinate enrollment with the treating cardiology team.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Diagnostic evaluation &amp; interpretation<\/h2>\n\n\n\n<p>Phase II rehabilitation is not \u201cdiagnosed\u201d like a disease; it is planned and tailored using clinical assessment. Common evaluation elements include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Clinical history and risk review<\/strong><\/li>\n<li>Index event\/procedure details (MI, PCI, CABG, valve intervention, HF admission).<\/li>\n<li>Current symptom inventory: chest discomfort, dyspnea, palpitations, presyncope\/syncope, leg swelling, claudication, fatigue.<\/li>\n<li>\n<p>Review of comorbidities (diabetes, chronic kidney disease, chronic obstructive pulmonary disease, peripheral artery disease) and orthopedic limitations.<\/p>\n<\/li>\n<li>\n<p><strong>Medication review and adherence assessment<\/strong><\/p>\n<\/li>\n<li>Understanding indications and common side effects that may affect exercise tolerance (for example, beta-blocker\u2013related chronotropic limitation, vasodilator-related lightheadedness).<\/li>\n<li>\n<p>Identification of barriers: cost, complexity, adverse effects, health literacy, and access.<\/p>\n<\/li>\n<li>\n<p><strong>Baseline cardiovascular assessment<\/strong><\/p>\n<\/li>\n<li>Vital signs and focused exam (volume status, murmurs, edema, lung findings).<\/li>\n<li>\n<p>Electrocardiogram (ECG) review when relevant, especially for conduction disease, prior infarct patterns, or baseline ST-T abnormalities.<\/p>\n<\/li>\n<li>\n<p><strong>Functional capacity assessment<\/strong><\/p>\n<\/li>\n<li>Many programs use an exercise test (treadmill or cycle) or a standardized functional test (such as walk-based assessments) to guide initial exercise prescription.<\/li>\n<li>\n<p>Interpretation emphasizes patterns rather than single numbers: symptom reproduction, blood pressure response, heart rate response (including medication effects), ECG changes when monitored, and recovery dynamics.<\/p>\n<\/li>\n<li>\n<p><strong>Ongoing session monitoring<\/strong><\/p>\n<\/li>\n<li>Depending on patient risk and program design, monitoring may include ECG telemetry, intermittent heart rate and blood pressure checks, symptom ratings, and perceived exertion scales.<\/li>\n<li>Concerning findings are interpreted in clinical context; next steps may include communication with the treating clinician, adjustment of exercise intensity, or additional diagnostic evaluation as appropriate.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Management overview (General approach)<\/h2>\n\n\n\n<p>Cardiac Rehabilitation Phase II is best understood as a structured, interdisciplinary outpatient program that integrates exercise, education, and risk reduction. The exact content varies by protocol and patient factors, but common components include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Supervised exercise training<\/strong><\/li>\n<li>Typically includes aerobic conditioning (walking, cycling, treadmill) and may include resistance training and flexibility\/balance work.<\/li>\n<li>Intensity is individualized based on baseline assessment, symptoms, comorbidities, and clinical stability.<\/li>\n<li>\n<p>Staff monitor for symptoms and abnormal physiologic responses and support gradual progression.<\/p>\n<\/li>\n<li>\n<p><strong>Secondary prevention and education<\/strong><\/p>\n<\/li>\n<li><strong>Medication literacy:<\/strong> why medications are used, common adverse effects, and how they relate to risk reduction.<\/li>\n<li><strong>Risk factor management:<\/strong> blood pressure, lipids, diabetes, tobacco exposure, nutrition patterns, weight management, and sleep.<\/li>\n<li>\n<p><strong>Symptom recognition:<\/strong> differentiating expected exertional sensations from potentially concerning symptoms (taught in general, not as individualized medical advice).<\/p>\n<\/li>\n<li>\n<p><strong>Psychosocial and behavioral support<\/strong><\/p>\n<\/li>\n<li>Screening for mood symptoms, stress, and social barriers can be part of comprehensive programs.<\/li>\n<li>\n<p>Interventions may include counseling, stress management strategies, and referral pathways when needed.<\/p>\n<\/li>\n<li>\n<p><strong>Care coordination<\/strong><\/p>\n<\/li>\n<li>Rehabilitation teams often communicate with cardiologists, surgeons, primary care clinicians, and therapists.<\/li>\n<li>This coordination can help align exercise progression with surgical healing, device considerations, and medication titration plans.<\/li>\n<\/ul>\n\n\n\n<p>How Phase II fits into the broader pathway:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Acute care<\/strong> addresses immediate stabilization and procedural management.<\/li>\n<li><strong>Phase I<\/strong> begins mobilization and basic education.<\/li>\n<li><strong>Cardiac Rehabilitation Phase II<\/strong> advances conditioning and self-management skills in a monitored setting.<\/li>\n<li><strong>Long-term follow-up<\/strong> transitions toward independent activity and ongoing preventive care, sometimes with maintenance programs.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Complications, risks, or limitations<\/h2>\n\n\n\n<p>Phase II rehabilitation is designed to be structured and monitored, but it has potential risks and practical limitations. These are context-dependent and vary by protocol and patient factors.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Exercise-related cardiovascular events (uncommon but possible)<\/strong><\/li>\n<li>Angina or ischemic symptoms during exertion.<\/li>\n<li>Arrhythmias (for example, atrial fibrillation episodes or ventricular ectopy) in susceptible individuals.<\/li>\n<li>Abnormal blood pressure responses, including symptomatic hypotension or excessive hypertension.<\/li>\n<li>\n<p>Worsening heart failure symptoms in patients with limited reserve.<\/p>\n<\/li>\n<li>\n<p><strong>Non-cardiovascular risks<\/strong><\/p>\n<\/li>\n<li>Musculoskeletal strain or injury, particularly with deconditioning, arthritis, or post-sternotomy movement limitations after CABG.<\/li>\n<li>\n<p>Hypoglycemia or hyperglycemia risk in patients with diabetes, influenced by medications, meal timing, and exercise.<\/p>\n<\/li>\n<li>\n<p><strong>Contraindications and reasons to defer sessions<\/strong><\/p>\n<\/li>\n<li>Active, unstable symptoms (for example, ongoing chest pain at rest, uncontrolled arrhythmia symptoms, or acute decompensated HF) may prompt postponement and medical evaluation.<\/li>\n<li>\n<p>Specific criteria vary by clinician and case.<\/p>\n<\/li>\n<li>\n<p><strong>Limitations in real-world delivery<\/strong><\/p>\n<\/li>\n<li>Access barriers: transportation, work schedules, caregiving responsibilities, cost\/coverage, and geographic availability.<\/li>\n<li>Variation in monitoring intensity across programs, particularly in home-based models.<\/li>\n<li>Adherence challenges related to health literacy, mental health, and competing priorities.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Prognosis &amp; follow-up considerations<\/h2>\n\n\n\n<p>Prognosis after a cardiac event or procedure depends primarily on the underlying disease process (extent of coronary disease, LV function, valvular pathology, arrhythmia substrate), comorbidities, and the degree of sustained risk-factor control. Cardiac Rehabilitation Phase II is one element within that broader trajectory and is often used to support functional recovery and reinforce secondary prevention strategies.<\/p>\n\n\n\n<p>Follow-up considerations commonly include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Functional trajectory<\/strong><\/li>\n<li>\n<p>Many patients aim to regain confidence with daily activities and return to work or recreational activity. The pace of improvement varies by baseline conditioning, event severity, and comorbidities.<\/p>\n<\/li>\n<li>\n<p><strong>Symptom evolution<\/strong><\/p>\n<\/li>\n<li>Rehabilitation provides repeated data points: whether exertional dyspnea is improving, whether chest discomfort recurs with predictable triggers, and whether palpitations or presyncope occur during or after exercise.<\/li>\n<li>\n<p>New or changing symptoms generally prompt clinical reassessment pathways, which vary by clinician and case.<\/p>\n<\/li>\n<li>\n<p><strong>Medication and risk-factor adherence<\/strong><\/p>\n<\/li>\n<li>Long-term outcomes are influenced by ongoing adherence to prescribed therapies and sustainable lifestyle patterns.<\/li>\n<li>\n<p>Programs often emphasize practical skills: understanding medication purpose, maintaining activity routines, and engaging in follow-up care.<\/p>\n<\/li>\n<li>\n<p><strong>Transition planning<\/strong><\/p>\n<\/li>\n<li>As Phase II ends, many patients transition to independent exercise, community programs, or maintenance rehabilitation (Phase III\/IV terminology varies).<\/li>\n<li>Follow-up may include continued cardiology oversight, periodic functional reassessment, and ongoing management of blood pressure, lipids, diabetes, and HF status when relevant.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Cardiac Rehabilitation Phase II Common questions (FAQ)<\/h2>\n\n\n\n<p><strong>Q: What does Cardiac Rehabilitation Phase II mean in plain language?<\/strong><br\/>\nIt refers to a supervised outpatient program designed to help people recover after a cardiac event or procedure. It combines monitored exercise with education and risk-factor management. It is a care pathway rather than a diagnosis.<\/p>\n\n\n\n<p><strong>Q: How is Phase II different from Phase I cardiac rehabilitation?<\/strong><br\/>\nPhase I usually occurs in the hospital and focuses on early mobilization and basic education during acute recovery. Cardiac Rehabilitation Phase II occurs after discharge in an outpatient setting and emphasizes structured, progressive exercise and longer-term self-management skills. The intensity and monitoring are typically greater than in Phase I.<\/p>\n\n\n\n<p><strong>Q: Who is commonly referred to Cardiac Rehabilitation Phase II?<\/strong><br\/>\nCommon referrals include patients after myocardial infarction (MI), PCI (stent placement), CABG, valve interventions, or stable heart failure (HF). Eligibility and timing vary by clinician and case. Programs tailor plans to the individual\u2019s diagnosis, symptoms, and functional status.<\/p>\n\n\n\n<p><strong>Q: Is Cardiac Rehabilitation Phase II the same as a stress test?<\/strong><br\/>\nNo. A stress test is a diagnostic evaluation used to assess physiologic responses to exercise and possible ischemia or arrhythmias. Phase II rehabilitation may use exercise testing to help set safe starting levels, but the program itself is ongoing therapy and education rather than a single test.<\/p>\n\n\n\n<p><strong>Q: What is typically monitored during sessions?<\/strong><br\/>\nMonitoring may include symptoms, heart rate, blood pressure, and sometimes ECG telemetry, depending on program design and patient risk profile. Staff also track perceived exertion and recovery after activity. The specific monitoring approach varies by protocol and patient factors.<\/p>\n\n\n\n<p><strong>Q: What kinds of exercise are included?<\/strong><br\/>\nPrograms commonly use aerobic exercise (walking, treadmill, cycling) and may add resistance training and flexibility or balance work. The plan is individualized to clinical status, comorbidities, and orthopedic constraints. Progression is typically gradual and guided by observed responses.<\/p>\n\n\n\n<p><strong>Q: What symptoms during rehabilitation are considered clinically important to report?<\/strong><br\/>\nEducational programs often emphasize reporting chest discomfort, unusual shortness of breath, palpitations with lightheadedness, near-fainting, or marked exercise intolerance compared with prior sessions. These symptoms can have many causes, and interpretation depends on clinical context. Programs generally have protocols for escalation when concerning patterns appear.<\/p>\n\n\n\n<p><strong>Q: How does Cardiac Rehabilitation Phase II relate to long-term prevention?<\/strong><br\/>\nPhase II reinforces secondary prevention habits\u2014medication understanding, activity routines, and risk-factor management. It can also help identify barriers to adherence, such as side effects, cost, or fear of exertion. Long-term risk reduction typically depends on sustained follow-through after the program ends.<\/p>\n\n\n\n<p><strong>Q: Can people return to work or sports after Phase II?<\/strong><br\/>\nReturn to work or sports depends on the underlying condition, functional capacity, job demands, symptoms, and clinician recommendations. Phase II can help document functional progress and build confidence with graded activity. Decisions are individualized and vary by clinician and case.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cardiac Rehabilitation Phase II is a structured, medically supervised outpatient rehabilitation program after a cardiac event or procedure. It is a therapeutic care pathway, not a diagnosis or a test. It is commonly encountered after myocardial infarction (MI), percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), valve procedures, or heart failure (HF) stabilization. It combines monitored exercise training with education and risk-factor management to support safer recovery and long-term cardiovascular health.<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-637","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts\/637","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/comments?post=637"}],"version-history":[{"count":0,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts\/637\/revisions"}],"wp:attachment":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/media?parent=637"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/categories?post=637"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/tags?post=637"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}